Skip to main content

Nasdaq Earnings

Earnings Strength and Market Weakness

5 years 8 months ago
The market appears to be shrugging the very strong and reassuring run of quarterly earnings results, with unusual and speculative trading activities in a few heavily shorted stocks dominating the market discourse.
Zacks

Earnings Strength and Market Weakness

5 years 8 months ago
The market appears to be shrugging the very strong and reassuring run of quarterly earnings results, with unusual and speculative trading activities in a few heavily shorted stocks dominating the market discourse.
Zacks

Earnings Strength and Market Weakness

5 years 8 months ago
The market appears to be shrugging the very strong and reassuring run of quarterly earnings results, with unusual and speculative trading activities in a few heavily shorted stocks dominating the market discourse.
Zacks

Earnings Strength and Market Weakness

5 years 8 months ago
The market appears to be shrugging the very strong and reassuring run of quarterly earnings results, with unusual and speculative trading activities in a few heavily shorted stocks dominating the market discourse.
Zacks

Earnings Strength and Market Weakness

5 years 8 months ago
The market appears to be shrugging the very strong and reassuring run of quarterly earnings results, with unusual and speculative trading activities in a few heavily shorted stocks dominating the market discourse.
Zacks

Earnings Strength and Market Weakness

5 years 8 months ago
The market appears to be shrugging the very strong and reassuring run of quarterly earnings results, with unusual and speculative trading activities in a few heavily shorted stocks dominating the market discourse.
Zacks

Earnings Strength and Market Weakness

5 years 8 months ago
The market appears to be shrugging the very strong and reassuring run of quarterly earnings results, with unusual and speculative trading activities in a few heavily shorted stocks dominating the market discourse.
Zacks

Earnings Strength and Market Weakness

5 years 8 months ago
The market appears to be shrugging the very strong and reassuring run of quarterly earnings results, with unusual and speculative trading activities in a few heavily shorted stocks dominating the market discourse.
Zacks

Earnings Strength and Market Weakness

5 years 8 months ago
The market appears to be shrugging the very strong and reassuring run of quarterly earnings results, with unusual and speculative trading activities in a few heavily shorted stocks dominating the market discourse.
Zacks

Earnings Strength and Market Weakness

5 years 8 months ago
The market appears to be shrugging the very strong and reassuring run of quarterly earnings results, with unusual and speculative trading activities in a few heavily shorted stocks dominating the market discourse.
Zacks

Earnings Strength and Market Weakness

5 years 8 months ago
The market appears to be shrugging the very strong and reassuring run of quarterly earnings results, with unusual and speculative trading activities in a few heavily shorted stocks dominating the market discourse.
Zacks

Earnings Strength and Market Weakness

5 years 8 months ago
The market appears to be shrugging the very strong and reassuring run of quarterly earnings results, with unusual and speculative trading activities in a few heavily shorted stocks dominating the market discourse.
Zacks

3 MedTech Stocks Likely to Top Estimates This Earnings Season

5 years 8 months ago
Fourth-quarter results of Medical Products companies within the broader Medical sector are expected to reflect strong rebound in procedure volume as a result of pent-up demand. This basically is the consequence of subdued consumer spending in the form of deferral of non-electiv
Zacks

3 MedTech Stocks Likely to Top Estimates This Earnings Season

5 years 8 months ago
Fourth-quarter results of Medical Products companies within the broader Medical sector are expected to reflect strong rebound in procedure volume as a result of pent-up demand. This basically is the consequence of subdued consumer spending in the form of deferral of non-electiv
Zacks

3 MedTech Stocks Likely to Top Estimates This Earnings Season

5 years 8 months ago
Fourth-quarter results of Medical Products companies within the broader Medical sector are expected to reflect strong rebound in procedure volume as a result of pent-up demand. This basically is the consequence of subdued consumer spending in the form of deferral of non-electiv
Zacks

3 MedTech Stocks Likely to Top Estimates This Earnings Season

5 years 8 months ago
Fourth-quarter results of Medical Products companies within the broader Medical sector are expected to reflect strong rebound in procedure volume as a result of pent-up demand. This basically is the consequence of subdued consumer spending in the form of deferral of non-electiv
Zacks
Checked
26 minutes 9 seconds ago
This feed is responsible for generating the rss feed related to the topic Earnings
Subscribe to Nasdaq Earnings feed